Modern Diagnostic & Research Centre (BOM:544673) ROCE %: 9.87% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:544673 Modern Diagnostic & Research Centre Ltd BOM:544673
15 GF Score
Price ₹51.00
! 7 Warning Signs
View Full Analysis

What is Modern Diagnostic & Research Centre ROCE %?

Modern Diagnostic & Research Centre BOM:544673 15 ROCE % is 9.87% as of Mar. 2026. GuruFocus rates BOM:544673 with a GF Score™ of 15/100. The stock has 7 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Modern Diagnostic & Research Centre's annualized ROCE % for the quarter that ended in Mar. 2026 was 9.87%.


Modern Diagnostic & Research Centre  (BOM:544673) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.


Modern Diagnostic & Research Centre ROCE % Related Terms


Modern Diagnostic & Research Centre ROCE % Historical Data

* Premium members only.

The historical data trend for Modern Diagnostic & Research Centre's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Modern Diagnostic & Research Centre ROCE % Chart

Modern Diagnostic & Research Centre Annual Data
Trend Mar23 Mar24 Mar25 Mar26
ROCE %
-29.69 42.39 50.68 15.64

Modern Diagnostic & Research Centre Semi-Annual Data
Mar23 Mar24 Mar25 Mar26
ROCE % 0.00 0.00 0.00 9.87
BOM:544673
15GF Score
Modern Diagnostic & Research Centre Ltd BOM:544673
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Modern Diagnostic & Research Centre ROCE % Calculation

Modern Diagnostic & Research Centre's annualized ROCE % for the fiscal year that ended in Mar. 2026 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Mar. 2026 )  (A: Mar. 2025 )(A: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Mar. 2026 )  (A: Mar. 2025 )(A: Mar. 2026 )
=84.313/( ( (645.743 - 319.172) + (1185.982 - 434.413) )/ 2 )
=84.313/( (326.571+751.569)/ 2 )
=84.313/539.07
=15.64 %

Modern Diagnostic & Research Centre's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Mar. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Mar. 2025 )(Q: Mar. 2026 )
=53.23/( ( (645.743 - 319.172) + (1185.982 - 434.413) )/ 2 )
=53.23/( ( 326.571 + 751.569 )/ 2 )
=53.23/539.07
=9.87 %

(1) Note: The EBIT data used here is two times the semi-annual (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 9.87% mean?
Modern Diagnostic & Research Centre (BOM:544673) has a ROCE % of 9.87% as of Mar. 2026.
Is Modern Diagnostic & Research Centre's ROCE % too high?
Modern Diagnostic & Research Centre's current ROCE % is 9.87%. Overall, Modern Diagnostic & Research Centre has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does Modern Diagnostic & Research Centre's ROCE % compare to TMO and DHR?
Modern Diagnostic & Research Centre's ROCE % of 9.87% can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Medical Diagnostics & Research company?
A good ROCE % depends on the Medical Diagnostics & Research industry context. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. Modern Diagnostic & Research Centre's current ROCE % is 9.87%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Modern Diagnostic & Research Centre stock overvalued right now?
Modern Diagnostic & Research Centre (BOM:544673) has a current ROCE % of 9.87%. The current ROCE % is 9.87%. Modern Diagnostic & Research Centre's overall GF Score™ is 15/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Modern Diagnostic & Research Centre (BOM:544673), the current ROCE % is 9.87% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Modern Diagnostic & Research Centre Business Description

Address New Railway Road, 363/4 Jawahar Nagar, Sadar Bazar, Gurugram, HR, IND, 122001
Modern Diagnostic & Research Centre Ltd is a services provider in diagnostic and related healthcare tests services in India. It offers a one-stop solution for pathology and radiology testing services such as imaging (including radiology), pathology/clinical laboratory. Through Its integrated, nationwide network, it offers a complete range of diagnostic facilities in radiology and pathology. The company provides healthcare tests and services for use in core testing, patients' diagnosis and prevention, monitoring of disease and other health conditions. Its customers include individual patients, hospitals and other healthcare providers and corporate customers.
15GF Score

Get the complete analysis for BOM:544673

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹51.00
Price